Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease

Clin Auton Res. 2017 Jul;27(Suppl 1):9-11. doi: 10.1007/s10286-017-0428-4. Epub 2017 Jul 11.

Authors

Fiona Gupta¹, Daniel Kremens², Steven Vernino³, Beverly Karabin⁴

Affiliations

¹ Movement Disorders Center, Hackensack University Medical Center, Hackensack, NJ, USA. [email protected].
² Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
³ Department of Neurology, UT Southwestern, Dallas, TX, USA.
⁴ Syncope and Autonomic Disorders Center, University of Toledo, Toledo, OH, USA.

No abstract available

Keywords: Droxidopa; Neurogenic orthostatic hypotension; Parkinson’s disease; Pure autonomic failure.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antiparkinson Agents / therapeutic use*
Autonomic Nervous System Diseases / complications
Autonomic Nervous System Diseases / drug therapy
Diagnosis, Differential
Dopamine Agents / therapeutic use
Droxidopa / therapeutic use*
Female
Humans
Hypotension, Orthostatic / complications
Hypotension, Orthostatic / drug therapy*
Middle Aged
Pure Autonomic Failure / diagnosis
Pure Autonomic Failure / drug therapy
Syncope / complications
Syncope / drug therapy

Substances

Antiparkinson Agents
Dopamine Agents
Droxidopa